| Literature DB >> 30633339 |
Christian J Jimenez1, Jiacheng Tan1, Kalli M Dowell1, Gillian E Gadbois1, Cameron A Read1, Nicole Burgess1, Jesus E Cervantes1, Shannon Chan1, Anmol Jandaur1, Tara Karanik1, Jaenic J Lee1, Mikaela C Ley1, Molly McGeehan1, Ann McMonigal1, Kira L Palazzo1, Samantha A Parker1, Andre Payman1, Maritza Soria1, Lauren Verheyden1, Vivian T Vo1, Jennifer Yin1, Anna L Calkins1, Amelia A Fuller1, Grace Y Stokes1.
Abstract
Peptoids are versatile peptidomimetic molecules with wide-ranging applications from drug discovery to materials science. An understanding of peptoid sequence features that contribute to both their three-dimensional structures and their interactions with lipids will expand functions of peptoids in varied fields. Furthermore, these topics capture the enthusiasm of undergraduate students who prepare and study diverse peptoids in laboratory coursework and/or in faculty led research. Here, we present the synthesis and study of 21 peptoids with varied functionality, including 19 tripeptoids and 2 longer oligomers. We observed differences in fluorescence spectral features for 10 of the tripeptoids that correlated with peptoid flexibility and relative positioning of chromophores. Interactions of representative peptoids with sonicated glycerophospholipid vesicles were also evaluated using fluorescence spectroscopy. We observed evidence of conformational changes effected by lipids for select peptoids. We also summarize our experiences engaging students in peptoid-based projects to advance both research and undergraduate educational objectives in parallel.Entities:
Keywords: chemistry education; fluorescence spectroscopy; peptidomimetics; phospholipid membranes; sequence-structure relationships
Mesh:
Substances:
Year: 2019 PMID: 30633339 PMCID: PMC6590334 DOI: 10.1002/bip.23256
Source DB: PubMed Journal: Biopolymers ISSN: 0006-3525 Impact factor: 2.505
Figure 1Structures of molecules used in these studies. A, Sub‐monomer synthesis method for preparation of peptoids. B, Amines with varied functionality were used to install side chain functionality sequence‐specifically in an array of 19 tripeptoids and 2 longer peptoid sequences. C, Structure of 1,2‐dioleoyl‐sn‐glycero‐3‐phosphocholine (DOPC) lipid used to prepare small unilamellar vesicles as PM mimics
Figure 2Structures of all peptoids prepared in this work. Boxed structures were studied by fluorescence spectroscopy as detailed in the text
Timeline for laboratory activities in tripeptoid synthesis experiments
| Week | Laboratory lecture topics | Student presentation topics | Laboratory technique demonstrations | Student laboratory tasks |
|---|---|---|---|---|
| 1 |
Peptoids and their utility Sub‐monomer peptoid synthesis Solid‐phase synthesis Combinatorial chemistry Protecting groups Introduction to syringe |
Synthesis vessel usage |
Swell resin Deprotect resin Identify amines for use, do calculations for preparation of at least one amine solution Draw target product in ChemDraw, generate molecular weight | |
| 2 |
Understanding peptoid‐lipid interactions using second harmonic generation spectroscopy |
Mechanism: Fmoc removal Peptoid applications in the literature |
Chloranil test |
Bromoacetylation reaction Amine displacement reaction Bromoacetylation reaction Prepare amine solution |
| 3 |
Mechanisms: bromoacetylation reaction, amine displacement reaction Peptoid applications in the literature |
Amine displacement reaction Bromoacetylation reaction Amine displacement reaction | ||
| 4 |
Introduction to Liquid chromatography‐mass spectrometry (LC‐MS) instrumentation and techniques |
Mechanisms: chloranil test, cleavage from resin, side chain deprotection Peptoid applications in the literature |
LC‐MS sample preparation |
Cleave tripeptoid from resin Prepare sample for LC‐MS analysis |
| 5 |
Introduction to LC‐MS data analysis |
Analysis of LC‐MS data |
Summary of fluorescence emission observations for tripeptoids
| Tripeptoid |
|
|
|
|
|
|---|---|---|---|---|---|
|
| 335 | 4.04 | 6.88 | 2.68 | 1.58 |
|
| 341 | 1.38 | 1.12 | 1.39 | 1.72 |
|
|
|
|
|
| |
|
| 338 | 5.21 | 6.70 | 2.34 | 1.81 |
|
| 339 | 0.96 | 0.90 | 1.71 | 1.84 |
|
|
|
|
|
| |
|
| 335 | 1.27 | 1.02 | 0.97 | 1.21 |
|
| 335 | 2.10 | 2.00 | 1.26 | 1.32 |
|
| 335 | 3.53 | 3.62 | 1.83 | 1.78 |
|
| 335 | 1.81 | 1.57 | 1.39 | 1.61 |
|
| 335 | 3.31 | 4.42 | 2.13 | 1.59 |
|
| 335 | 1.28 | 1.17 | 1.25 | 1.36 |
λ max emission in pH 7.4 buffer in the absence of small unilamellar vesicles (SUVs).
Ratio of fluorescence emission intensity at λ max for solutions of peptoid at pH 5.0 and pH 7.4.
Ratio of fluorescence emission intensity at λ max for solutions of peptoid in the presence and absence of 16.6‐fold excess of SUVs. Data for excimer peaks are given in bold.
Figure 3Fluorescence emission spectra of tripeptoids I, M, N, O, R, and S (panels A and B) and A, B, C, and D (panels C and D). Experiments were conducted at pH 7.4 (panels A and C) and at pH 5.0 (panels B and D). Dissolved peptoid concentrations were maintained at 100 μM. Data were normalized to the lower wavelength peak for each peptoid sequence at pH 5.0
Figure 4Difference in fluorescence emission intensities in the presence minus in the absence of SUVs composed of DOPC for tripeptoids A, B, C, D, I, and R. Experiments were conducted at pH 5.0. Dissolved peptoid concentrations were maintained at 100 μM. A lipid‐to‐peptoid molar ratio of 16.6:1 was used for all peptoid sequences
Figure 5Fluorescence spectra of peptoids T (black) and U (red) in the absence (solid lines) and presence (dashed lines) of SUVs composed of DOPC. Experiments were conducted at pH 7.4. Dissolved peptoid concentrations were maintained at 40 μM and a lipid‐to‐peptoid molar ratio of 100:1 was used
Summary of fluorescence emission observations for longer peptoids
| Peptoid |
|
|
|---|---|---|
|
| 338 | 0.97 |
|
| 340 | 1.30 |
|
|
|
λ max emission in pH 7.4 buffer in the absence of lipid vesicles.
Ratio of fluorescence emission intensity at λ max for solutions of peptoid in the presence and absence of 100‐fold excess of small unilamellar vesicles. Data for excimer peak are given in bold.